Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
New Insights into How Mutant p53 Promotes Tumor Growth

New Insights into How Mutant p53 Promotes Tumor Growth

Discovery of Immune Cell Reservoirs Near Glioblastomas Offers New Treatment Possibilities

Discovery of Immune Cell Reservoirs Near Glioblastomas Offers New Treatment Possibilities

3D Cell Cultures Improve Drug Screening Accuracy but Show Lower Efficacy for Anti-Cancer Drugs

3D Cell Cultures Improve Drug Screening Accuracy but Show Lower Efficacy for Anti-Cancer Drugs

Super-Cooled Brain Cell Molecules Shed Light on Epilepsy Drug Action

Super-Cooled Brain Cell Molecules Shed Light on Epilepsy Drug Action

Unlocking Glucose-Driven Mechanisms of Immunosuppression in Glioblastoma

Unlocking Glucose-Driven Mechanisms of Immunosuppression in Glioblastoma

Acidic Fortress of Tumors Could Rebuff Immune Cells

Acidic Fortress of Tumors Could Rebuff Immune Cells

Dual-Target CAR T Cell Therapy Shows Promise Against Recurrent Glioblastoma

Dual-Target CAR T Cell Therapy Shows Promise Against Recurrent Glioblastoma

Unveiling the Orchestration of Cells With Single-Cell Time Tracking

Unveiling the Orchestration of Cells With Single-Cell Time Tracking

SERS Decodes Cancer's Whispers: Metabolites Reveal Tumor Communication and Potential Targets

SERS Decodes Cancer's Whispers: Metabolites Reveal Tumor Communication and Potential Targets

Understudied Brain Cell Holds Key to Glioblastoma's Immunotherapy Resistance

Understudied Brain Cell Holds Key to Glioblastoma's Immunotherapy Resistance

Cancer Stem Cells Induce Macrophage Senescence, Creating Conditions for Tumor Formation

Cancer Stem Cells Induce Macrophage Senescence, Creating Conditions for Tumor Formation

DNA’s Role in Glioblastoma: Insights from Umeå University’s Research

DNA’s Role in Glioblastoma: Insights from Umeå University’s Research

New Atlases Reveal Unprecedented Detail of the Human Brain

New Atlases Reveal Unprecedented Detail of the Human Brain

Researchers Develop Drug Targeting lncRNA TUG1 to Control Brain Tumor Growth in Mice

Researchers Develop Drug Targeting lncRNA TUG1 to Control Brain Tumor Growth in Mice

Analyzing DNA Damage-Induced NF-κB Targeted by Novel Small Molecule Inhibitors

Analyzing DNA Damage-Induced NF-κB Targeted by Novel Small Molecule Inhibitors

Analyzing Glioma Progression and Implicating CPNs’ Long-Range Projections

Analyzing Glioma Progression and Implicating CPNs’ Long-Range Projections

Virus Plays Important Role in Treating Glioblastoma

Virus Plays Important Role in Treating Glioblastoma

Targeting Cellular Respiration for the Treatment of Glioblastoma

Targeting Cellular Respiration for the Treatment of Glioblastoma

Mitochondria Transfer From Astrocytes Enhances Tumorigenesis in Glioblastoma

Mitochondria Transfer From Astrocytes Enhances Tumorigenesis in Glioblastoma

Cancer Stem Cell Test can Accurately Decide More Effective Treatments for Glioblastoma Patients

Cancer Stem Cell Test can Accurately Decide More Effective Treatments for Glioblastoma Patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.